Duquesne's big health gambit

Tue Jun 1, 2004



Stanley Druckenmiller does not like to tell people - even his investors - too much about his investments. This is a shame, as an analysis of recent Securities & Exchange Commission regulatory filings by Duquesne Capital Management suggests that the former Soros principal has some pretty wild tales to tell.

Perhaps few would be as interesting as a recent big gambit by Duquesne on scandal-ridden service provider Healthsouth. At the start of the second quarter, Healthsouth was one of the largest holdings in the Duquesne portfolio of more than 200 positions. In fact, Duquesne held a hefty 9.1 million shares, worth $37.4 million, up from a 100,000-share stake at the start of the year, according to regulatory filings.

It was a pretty brave bet. Although some analysts have put a $12 target on the stock for when the Alabama-based company gets its fiscal house in order, most institutional investors...

ISSN: 2151-1845 / CDC10004H

TAKE A FREE TRIAL

The full contents of this article are available to active AR subscribers and trialists only.

To continue reading please,
take a free trialsubscribe or log in to AR.

Subscribe

Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.

Subscribe now